We are live on ! Find out more
SGM

Seven Grand Managers Portfolio holdings

AUM $1.5B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+57.16%
3 Year Est. Return
+233.02%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.31B
AUM Growth
+$81.9M
Cap. Flow
+$99.5M
Cap. Flow %
7.58%
Top 10 Hldgs %
33.34%
Holding
168
New
69
Increased
12
Reduced
18
Closed
30

Top Buys

Rank Stock Value
1
MDLN
Medline Inc
MDLN
+$48.6M
2
ITT icon
ITT
ITT
+$44.8M
3
HON icon
Honeywell
HON
+$31.5M
4
COHR icon
Coherent
COHR
+$29.9M
5
ACHR icon
Archer Aviation
ACHR
+$28.2M

Top Sells

Rank Stock Value
1
MCK icon
McKesson
MCK
+$46.4M
2
MBLY icon
Mobileye
MBLY
+$28.2M
3
TTWO icon
Take-Two Interactive
TTWO
+$25.8M
4
ESLT icon
Elbit Systems
ESLT
+$25.5M
5
GLXY
Galaxy Digital Inc
GLXY
+$23.2M

Sector Composition

Rank Sector Weight
1 Industrials 22.78%
2 Technology 22.58%
3 Financials 16.55%
4 Healthcare 16.08%
5 Consumer Discretionary 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DRUG
76
Bright Minds Biosciences
DRUG
$697M
$3.9M 0.3%
+50,000
New +$3.34M
BBIO icon
77
BridgeBio Pharma
BBIO
$16.4B
$3.82M 0.29%
+50,000
New +$3.28M
CHYM
78
Chime Financial
CHYM
$8.54B
$3.78M 0.29%
150,000
– –
APGE icon
79
Apogee Therapeutics
APGE
$10.1B
$3.77M 0.29%
+50,000
New +$3.15M
SNPS icon
80
Synopsys
SNPS
$71.6B
$3.67M 0.28%
7,817
– –
XZO
81
Exzeo Group
XZO
$1.5B
$3.64M 0.28%
+150,000
New +$2.85M
OKLO
82
Oklo
OKLO
$6.41B
$3.59M 0.27%
50,000
-50,000
-50% -$5.58M
VIK icon
83
Viking Holdings
VIK
$45.8B
$3.57M 0.27%
+50,000
New +$3.19M
ETOR
84
eToro Group
ETOR
$2.87B
$3.51M 0.27%
100,000
– –
GPCR icon
85
Structure Therapeutics
GPCR
$3.37B
$3.48M 0.26%
+50,000
New +$2.04M
HGV icon
86
Hilton Grand Vacations
HGV
$4.04B
$3.36M 0.26%
75,000
-75,000
-50% -$3.19M
FLY
87
Firefly Aerospace
FLY
$2.93B
$3.36M 0.26%
150,000
– –
AERO
88
Grupo Aeromexico SAB de CV
AERO
$2.2B
$3.29M 0.25%
+150,000
New +$2.87M
SYRE icon
89
Spyre Therapeutics
SYRE
$8.5B
$3.28M 0.25%
+100,000
New +$2.61M
ARX
90
Accelerant Holdings
ARX
$2.71B
$3.27M 0.25%
200,000
– –
BGSI
91
Boyd Group Services
BGSI
$3.07B
$3.19M 0.24%
+20,000
New +$3.2M
VRDN icon
92
Viridian Therapeutics
VRDN
$2.2B
$3.11M 0.24%
+100,000
New +$2.74M
DFTX
93
Definium Therapeutics
DFTX
$5.6B
$3.01M 0.23%
+225,000
New +$2.78M
GRDN
94
Guardian Pharmacy Services
GRDN
$2.6B
$3.01M 0.23%
100,000
– –
MDU icon
95
MDU Resources
MDU
$4.18B
$2.93M 0.22%
+150,000
New +$2.95M
HTFL
96
Heartflow Inc
HTFL
$2.16B
$2.92M 0.22%
100,000
+50,000
+100% +$1.61M
CAPR icon
97
Capricor Therapeutics
CAPR
$2.89M 0.22%
+100,000
New +$1.31M
DLO icon
98
dLocal
DLO
$4.29B
$2.83M 0.22%
200,000
– –
IRON icon
99
Disc Medicine
IRON
$2.81B
$2.78M 0.21%
+35,000
New +$2.96M
KMTS
100
Kestra Medical Technologies
KMTS
$1.33B
$2.65M 0.2%
+100,000
New +$2.58M
2 3
4
5 6

Similar funds

CPA
Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return
RCW
Rheos Capital Works Tokyo, Japan $1.5B AUM 47.78% 1-Year Est. Return
MCM
Maple Capital Management Montpelier, Vermont $1.49B AUM 23.46% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
JFGLC
Johnson Financial Group LLC (Colorado) Denver, Colorado $1.5B AUM 16.09% 1-Year Est. Return

Seven Grand Managers's Q4 2025 Portfolio in Review

As of Q4 2025, Seven Grand Managers held 168 positions worth $1.31B, up 6.7% from $1.23B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Seven Grand Managers deployed $99.5M of net new capital in Q4 2025, opening 69 new positions and adding to 12 existing holdings. Its largest new stake was Medline Inc: 1,150,000 shares worth $48.3M.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 19% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Galaxy Digital Inc, an estimated $23.2M trimmed.

  • Seven Grand Managers's largest Q4 2025 buy was Medline Inc: 1,150,000 shares worth $48.3M.
  • Seven Grand Managers added most to Microsoft in Q4 2025, an estimated $28.1M increase.
  • Seven Grand Managers's biggest Q4 2025 reduction was Galaxy Digital Inc, cutting an estimated $23.2M.
  • Seven Grand Managers fully exited McKesson in Q4 2025, selling an estimated $46.4M.
  • Seven Grand Managers's ten largest holdings make up 33% of its $1.31B portfolio in Q4 2025.
  • Seven Grand Managers opened 69 new positions and closed 30 in Q4 2025.
  • Seven Grand Managers's portfolio value rose 6.7% quarter-over-quarter to $1.31B.

Based on Seven Grand Managers's 13F filing for Q4 2025, filed 10 Feb 2026.